Allosterix Overview

  • Founded
  • 2006
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Allosterix General Information


Developer of medical technology designed for locating allosteric sites and peptidic drug design. The company's technology platform for the design of drug-able enzyme inhibitors that locates an allosteric site in any target enzyme and designs a short peptide molecule to bind it, offering drug discoverers with discovery partnering and consulting work.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
  • Nurit 3 Street
  • D.N. Merkaz
  • Moshav Shilat 73188
  • Israel
+972 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Allosterix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Dec-2012 Completed Out of Business
1. Early Stage VC 01-Mar-2008 Completed Startup
To view Allosterix’s complete valuation and funding history, request access »